Back

Progressive fibrosis burden and primary prevention ICD decision in hypertrophic cardiomyopathy: a genetics- and imaging-based case

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Hypertrophic cardiomyopathy across time: early clues, evolving phenotypes, and risk Implantable Cardioverter-Defibrillator (ICD) Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Omer Gok

Istanbul University-Cerrahpasa Institute of Cardiology, Istanbul (Turkiye)

3 More presentations in this session

Presentation thumbnail
Obstruction-driven HFpEF in hypertrophic cardiomyopathy: a multimodal, guideline-based approach
Doctor F. Giru (Timisoara, RO)
Presentation thumbnail
Unmasking hypertrophic cardiomyopathy in women: the challenge of early detection
Doctor M. Barki (Milan, IT)
Presentation thumbnail
The thinner the better? A journey through the clinical evolution of hypertrophic cardiomyopathy
Doctor A. Parodi (Padova, IT)

Access the full session

Session thumbnail
Hypertrophic cardiomyopathy across time: early clues, evolving phenotypes, and risk

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026
You may be interested in
thumbnail
Congress Session
Debate on primary prevention in ICD therapy
thumbnail
Congress Session
Implantable cardioverter defibrillator therapy
thumbnail
Congress Session
Hot topics in the management of ventricular tachycardia and sudden cardiac death

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources